Latest filing published 06 Feb 2025 for Verrica Pharmaceuticals Inc..
Joe Bonaccorso is a declared insider of Verrica Pharmaceuticals Inc., with filings sourced from SEC (Form 4). The record holds 12 filings, for trades running from 19 June 2018 to 27 August 2024.
The open-market side counts 1 purchase for €13k alongside 7 sales for €501k. Sales outweigh purchases by €488k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants.
On 6 February 2025 came the latest disclosure, a share grant in Verrica Pharmaceuticals Inc. The latest purchase dates back some time: it was published 2,992 days ago, on 15 August 2018. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations